Escient Pharmaceuticals
Clinical trials sponsored by Escient Pharmaceuticals, explained in plain language.
Now part of
Incyte Corporation
INCY
NASDAQ
A clinical-stage biopharmaceutical company developing therapies for inflammatory and immune diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.